News and updates institute for child health policy
The ICHP Newsroom is the hub for faculty news and research, including press releases, upcoming events, announcements and media coverage.
News
UF researchers work to enhance HPV self-testing…
At-home kits that allow women to collect their own samples for HPV testing have been shown to improve cervical cancer screening rates. But some women…
Influential input at conference on dissemination…
One presentation reviews studies on HPV vaccination rates among adolescents and how clinicians offering vaccines may benefit from role playing and…
Implementing research on antibiotics for children…
What prescription advice would apply in the case of an 11-year-old boy with a cough and ear pain? This scenario is reviewed as part of an educational…
Grand Rounds
Advancing Black Maternal Healthcare
On March 20, 2024, Katilya Ware, PhD, RN, from Auburn University, gave a Grand Rounds presentation on “Bridging Gaps and Transforming Outcomes: Advancing Black Maternal Healthcare.”
HPV research
Cancer Research Showcase 2025
Student Sara Tohme shared a winning poster in the category for Predoctoral Students. The poster summarized research on educating vulnerable women on self-testing for the human papillomavirus (HPV).
Texas External Quality Review Organization
Three employees win Superior Accomplishment
Congratulations to three HOBI employees who received 2022-2023 Superior Accomplishment Awards for excellent work performance at the division level.
Employee & Student
Congratulations to doctoral graduate Sarah Chavez
Chavez worked full time as a research coordinator III for the Institute for Child Health Policy (ICHP) External Quality Review Organization (EQRO) project.
march 6, 2021
Straight talk about vaping for parents
Award
Grant to help UF Health researchers boost HPV vaccinations among youngsters
A team of UF Health researchers has received a five-year, $2.9 million grant from the National Cancer Institute to evaluate simple interventions aimed at health care providers and parents that could substantially boost vaccine rates for human papillomavirus, or HPV, among 11- and 12-year-olds.